Comparing Articular Noise and Its Perception Between Two Different Types of Total Knee Arthroplasty (NATKA)

March 2, 2026 updated by: Elsan

Monocentric, Randomized Study, Comparing Articular Noise and Its Perception Between Two Different Types of Total Knee Arthroplasty

Some patients complain of articular noise (such as clicking, snapping, cracking or popping) after a total knee replacement. Controversy remains about whether there is a correlation between articular noise and worse outcomes following a knee replacement. A study by Nam et al. on 1540 patients revealed an association between noise and residual symptoms 30 days after they received a total knee replacement. Conversely, a study by Kuriyama et al. on 60 patients revealed no correlation between noise and patient satisfaction after 1 year of receiving a total knee replacement. The incidence of noise following a knee replacement has rarely been studied as a primary outcome. Like pain, it could be considered an important patient-reported outcome to assess patient satisfaction. The study aims to compare the prevalence of patient-perceived noise of an ultra-congruent total knee prosthesis (Score 2, Amplitude) versus a posterior-stabilized total knee prosthesis (Anatomic, Amplitude).

Study Overview

Study Type

Interventional

Enrollment (Estimated)

170

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Stéphane Van DRIESSCHE, MD
  • Phone Number: +33(0)637675746
  • Email: svandri@gmail.com

Study Contact Backup

Study Locations

      • Auxerre, France, 89000
        • Recruiting
        • St Marguerite clinic
        • Contact:
          • Stephane Van Driessche, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adult patients receiving a primary TKA
  • Signed informed consent
  • Patients affiliated to a social security scheme
  • Patients willing and able to comply with study protocol requirements based on the investigator's judgment.

Exclusion Criteria:

  • History of knee surgery on the concerned/studied knee (except arthroscopic surgery)
  • Patients presenting coronal deformities > 20°, varus laxity > 10° and/or valgus laxity > 15°
  • Patients receiving revision TKA
  • Pregnancy or breast-feeding
  • Patients with protected status under articles L1121-6, LL121-8 and L1122-2 of the French Public Health Code
  • Unable to comply with study procedures, based on the investigator's judgment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: UC TKA
The Score II® is a primary cruciate-sacrificing TKA, with a single-radius femoral component that articulates in an ultra-congruent (UC) mobile-bearing tibial insert. The mobile-bearing tibial insert has high anterior and posterior borders to avoid anterior subluxation of the femoral condyles during knee flexion and a concave articular surface with a radius of curvature that matches that of the femoral component in the sagittal plane to ensure high congruence. The Score II® UC TKA comprises eight sizes and offers the choice of using a cemented or uncemented version. In this study, only the cemented version will be used.
Replacement of knee articulating surface for patients with end-stage osteoarthritis.
Other Names:
  • knee replacement
  • knee surgery
Active Comparator: PS TKA
The Anatomic® is a primary PS TKA with a fixed-bearing polyethylene insert. The femoral component has a cam design that engages on a tibial post to provide anterior-posterior stability during flexion. The Anatomic® PS TKA comprises nine cemented sizes. In this study, only the cemented version will be used. The Anatomic® PS TKA comprises nine cemented sizes.
Replacement of knee articulating surface for patients with end-stage osteoarthritis.
Other Names:
  • knee replacement
  • knee surgery

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence of articular noise
Time Frame: 2 years

The primary outcome is the prevalence of patients with articular noise at 2 years, evaluated by the Investigator during the follow-up visit through clinical examination and using the following question (Q1):

Q1: Do you hear noise? Never, rarely, sometimes, often, extremely often

2 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Noise characterisation: Discomfort
Time Frame: 1 year and 2 years

Characterisation of discomfort due to noise

Q2: Do you feel noise? (Never, rarely, sometimes, often, extremely often) Q3: Is the noise a concern, causing discomfort? (Never, rarely, sometimes, often, extremely often)

1 year and 2 years
Noise characterisation: Type
Time Frame: 1 and 2 years

Characterisation of the type of noise:

Q4: What kind of noise do you hear of feel? (Clunk, crepitus, grinding, clicking, other)

1 and 2 years
Noise characterisation: Location
Time Frame: 1 and 2 years

Characterisation of the location of noise:

Q5: What part of the knee is involved? (Patella, joint, both, other)

1 and 2 years
Noise characterisation: impact on quality of life
Time Frame: 1 and 2 years

Characterisation of impact on quality of life:

Q6: What is the impact of the noise on your quality of life, on a scale from 0 (none) to 10 (severe)?

1 and 2 years
Patient reported outcome score
Time Frame: 1 and 2 years
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC): worst, 96; best, 0
1 and 2 years

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient reported outcome score
Time Frame: 1 and 2 years
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC): worst, 96; best, 0
1 and 2 years
Forgotten joint
Time Frame: 1 and 2 years
Forgotten Joint Score (FJS): worst, 0; best, 100
1 and 2 years
Knee mobility: Maximum flexion
Time Frame: 3 weeks, 3 months, 1 years and 2 years
Clinical evaluation of knee mobility, using measurements of maximum flexion: degrees
3 weeks, 3 months, 1 years and 2 years
Knee mobility: flexion contracture
Time Frame: 3 weeks, 3 months, 1 years and 2 years
Clinical evaluation of knee mobility, using measurements of flexion contracture (FC): degrees
3 weeks, 3 months, 1 years and 2 years
Knee mobility: Range of motion
Time Frame: 3 weeks, 3 months, 1 years and 2 years
Clinical evaluation of knee mobility, using measurements of range of motion (ROM): degrees
3 weeks, 3 months, 1 years and 2 years
Joint pain
Time Frame: 3 weeks, 3 months, 1 year and 2 years
Pain assessment using the numeric scale (0 to 10): 0, no pain; 10, excruciating pain.
3 weeks, 3 months, 1 year and 2 years
Patient satisfaction
Time Frame: 1 and 2 years
Patient satisfaction assessed using a 5-point Likert scale (very satisfied, satisfied, neutral, dissatisfied, very dissatisfied).
1 and 2 years
Patient quality of life
Time Frame: 1 and 2 years
Patient QoL using the EQ-5D-5L questionnaire: 0, worst; 1, best.
1 and 2 years
Adverse events
Time Frame: 0 to 2 years
Analysis of adverse events: incidence, severity, and relationship to the medical device.
0 to 2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 24, 2025

Primary Completion (Estimated)

December 1, 2028

Study Completion (Estimated)

December 1, 2028

Study Registration Dates

First Submitted

March 4, 2025

First Submitted That Met QC Criteria

March 11, 2025

First Posted (Actual)

March 17, 2025

Study Record Updates

Last Update Posted (Actual)

March 4, 2026

Last Update Submitted That Met QC Criteria

March 2, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Upon a reasonable request, the authors will consider sharing anonymised data while adhering to French and European laws.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Replacement Arthroplasty

Clinical Trials on total knee arthroplasty

Subscribe